Fenmetramide

Fenmetramide
Clinical data
ATC code
  • None
Identifiers
  • 2-Phenyl-3-methyl-morpholin-5-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H13NO2
Molar mass191.230 g·mol−1
3D model (JSmol)
  • CC1C(OCC(=O)N1)C2=CC=CC=C2
  • InChI=1S/C11H13NO2/c1-8-11(14-7-10(13)12-8)9-5-3-2-4-6-9/h2-6,8,11H,7H2,1H3,(H,12,13)
  • Key:UJEPHPADGSWWRM-UHFFFAOYSA-N

Fenmetramide is a drug which was patented as an antidepressant by McNeil Laboratories in the 1960s.[1] The drug was never marketed.[2] It is the 5-ketone derivative of phenmetrazine and would similarly be expected to produce psychostimulant effects, though pharmacological data is lacking.

See also

References

  1. ^ US 3308121, Gannon WF, Poos GI, "3-Morpholinones, thiones and 5,6-oxazines", issued 7 March 1967, assigned to McNeil Laboratories 
  2. ^ Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.